123 related articles for article (PubMed ID: 30117240)
1. Discovery of a neuroendocrine tumor of the caecum by mammary metastasis using 18F-DOPA-PET.
Gornes H; Vaysse C; Deslandres M; Perallon R; Chantalat E; Rimailho J
J Obstet Gynaecol Res; 2018 Dec; 44(12):2195-2198. PubMed ID: 30117240
[TBL] [Abstract][Full Text] [Related]
2. 18F-fluorodihydroxyphenylalanine PET/CT in patients with neuroendocrine tumors of unknown origin: relation to tumor origin and differentiation.
Imperiale A; Rust E; Gabriel S; Detour J; Goichot B; Duclos B; Kurtz JE; Bachellier P; Namer IJ; Taïeb D
J Nucl Med; 2014 Mar; 55(3):367-72. PubMed ID: 24343986
[TBL] [Abstract][Full Text] [Related]
3. Role of 18F-dopa PET/CT imaging in the management of patients with 111In-pentetreotide negative GEP tumours.
Ambrosini V; Tomassetti P; Rubello D; Campana D; Nanni C; Castellucci P; Farsad M; Montini G; Al-Nahhas A; Franchi R; Fanti S
Nucl Med Commun; 2007 Jun; 28(6):473-7. PubMed ID: 17460538
[TBL] [Abstract][Full Text] [Related]
4. Comparison of (68)Ga-DOTA-Tyr(3)-octreotide and (18)F-fluoro-L-dihydroxyphenylalanine positron emission tomography in neuroendocrine tumor patients.
Putzer D; Gabriel M; Kendler D; Henninger B; Knoflach M; Kroiss A; Vonguggenberg E; Warwitz B; Virgolini IJ
Q J Nucl Med Mol Imaging; 2010 Feb; 54(1):68-75. PubMed ID: 20168288
[TBL] [Abstract][Full Text] [Related]
5. Primary Neuroendocrine Tumor in a Horseshoe Kidney With Positive 111In-Pentetreotide Somatostatin Receptor Scintigraphy and Negative 18F-DOPA PET/CT.
Gauthé M; Lièvre A; Alberini JL
Clin Nucl Med; 2015 Nov; 40(11):e516-7. PubMed ID: 26204216
[TBL] [Abstract][Full Text] [Related]
6. Value of combined 6-[18F]fluorodihydroxyphenylalanine PET/CT for imaging of neuroendocrine tumours.
Schiesser M; Veit-Haibach P; Muller MK; Weber M; Bauerfeind P; Hany T; Clavien PA
Br J Surg; 2010 May; 97(5):691-7. PubMed ID: 20225244
[TBL] [Abstract][Full Text] [Related]
7. A case report on metastatic ileal neuroendocrine neoplasm to the breast masquerading as primary breast cancer: A diagnostic challenge and management dilemma.
Papalampros A; Mpaili E; Moris D; Sarlanis H; Tsoli M; Felekouras E; Trafalis DT; Kontos M
Medicine (Baltimore); 2019 Apr; 98(16):e14989. PubMed ID: 31008928
[TBL] [Abstract][Full Text] [Related]
8. The clinical value of [18F]fluoro-dihydroxyphenylalanine positron emission tomography in primary diagnosis, staging, and restaging of neuroendocrine tumors.
Kauhanen S; Seppänen M; Ovaska J; Minn H; Bergman J; Korsoff P; Salmela P; Saltevo J; Sane T; Välimäki M; Nuutila P
Endocr Relat Cancer; 2009 Mar; 16(1):255-65. PubMed ID: 19088184
[TBL] [Abstract][Full Text] [Related]
9. Best sensitivity of
Testart Dardel N; Montravers F; Triviño-Ibañez E; Gauthé M; Houry S; Talbot JN
Rev Esp Med Nucl Imagen Mol; 2016; 35(6):402-405. PubMed ID: 27246293
[TBL] [Abstract][Full Text] [Related]
10. [Neuroendocrine tumor of the breast--metastasis or primary breast carcinoma? Case report].
Petrová M
Cesk Patol; 2015; 51(3):128-31. PubMed ID: 26421954
[TBL] [Abstract][Full Text] [Related]
11. 68Ga DOTANOC PET/CT in primary neuroendocrine tumor of the breast.
Mukherjee A; Karunanithi S; Singla S; Bal C; Kumar R
Clin Nucl Med; 2014 Apr; 39(4):396-8. PubMed ID: 24566407
[TBL] [Abstract][Full Text] [Related]
12. Myocardial metastases on 6-[18F] fluoro-L-DOPA PET/CT: a retrospective analysis of 116 serotonin producing neuroendocrine tumour patients.
Noordzij W; van Beek AP; Tio RA; van der Horst-Schrivers AN; de Vries EG; van Ginkel B; Walenkamp AM; Glaudemans AW; Slart RH; Dierckx RA
PLoS One; 2014; 9(11):e112278. PubMed ID: 25397775
[TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of bone metastases detected by
Deleval N; Pesque L; Dieudonné A; Viry F; Hentic O; Lebtahi R; Ruszniewski P; de Mestier L
Eur Radiol; 2021 Jun; 31(6):4166-4174. PubMed ID: 33247341
[TBL] [Abstract][Full Text] [Related]
14. 68Ga-DOTA-peptides versus 18F-DOPA PET for the assessment of NET patients.
Ambrosini V; Rubello D; Nanni C; Al-Nahhas A; Fanti S
Nucl Med Commun; 2008 May; 29(5):415-7. PubMed ID: 18391723
[No Abstract] [Full Text] [Related]
15. Octreoscan Versus FDG-PET for Neuroendocrine Tumor Staging: A Biological Approach.
Squires MH; Volkan Adsay N; Schuster DM; Russell MC; Cardona K; Delman KA; Winer JH; Altinel D; Sarmiento JM; El-Rayes B; Hawk N; Staley CA; Maithel SK; Kooby DA
Ann Surg Oncol; 2015 Jul; 22(7):2295-301. PubMed ID: 25786743
[TBL] [Abstract][Full Text] [Related]
16. 6-L-18F-fluorodihydroxyphenylalanine PET in neuroendocrine tumors: basic aspects and emerging clinical applications.
Jager PL; Chirakal R; Marriott CJ; Brouwers AH; Koopmans KP; Gulenchyn KY
J Nucl Med; 2008 Apr; 49(4):573-86. PubMed ID: 18344441
[TBL] [Abstract][Full Text] [Related]
17. 18F-DOPA PET/CT biodistribution consideration in 107 consecutive patients with neuroendocrine tumours.
Chondrogiannis S; Grassetto G; Marzola MC; Rampin L; Massaro A; Bellan E; Ferretti A; Mazza A; Al-Nahhas A; Rubello D
Nucl Med Commun; 2012 Feb; 33(2):179-84. PubMed ID: 22083098
[TBL] [Abstract][Full Text] [Related]
18. (68)Ga-DOTATATE PET/CT in the evaluation of patients with neuroendocrine metastatic carcinoma of unknown origin.
Alonso O; Rodríguez-Taroco M; Savio E; Bentancourt C; Gambini JP; Engler H
Ann Nucl Med; 2014 Aug; 28(7):638-45. PubMed ID: 24862238
[TBL] [Abstract][Full Text] [Related]
19. Radiolabelled somatostatin analogs for diagnosis and radio-guided surgery of neuroendocrine breast cancer undetectable with conventional imaging procedures.
Panareo S; Carcoforo P; Lanzara S; Corcione S; Bagatin E; Casali M; Costanzo A; Basaglia E; Feggi LM
Breast; 2008 Feb; 17(1):111-4. PubMed ID: 17869107
[TBL] [Abstract][Full Text] [Related]
20. Fluorine-18-L-dihydroxyphenylalanine (18F-DOPA) positron emission tomography as a tool to localize an insulinoma or beta-cell hyperplasia in adult patients.
Kauhanen S; Seppänen M; Minn H; Gullichsen R; Salonen A; Alanen K; Parkkola R; Solin O; Bergman J; Sane T; Salmi J; Välimäki M; Nuutila P
J Clin Endocrinol Metab; 2007 Apr; 92(4):1237-44. PubMed ID: 17227804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
